CURE.DE vs. SPYH.DE
CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) and SPYH.DE (SPDR MSCI Europe Health Care UCITS ETF) are both Health & Biotech Equities funds - CURE.DE tracks the MVIS Global Future Healthcare ESG while SPYH.DE tracks the MSCI Europe Health Care 20/35 Capped. Both are passively managed. Over the past 3 years, CURE.DE returned -2.48%/yr vs 2.85%/yr for SPYH.DE. At a 0.42 correlation, their price movements are largely independent. CURE.DE charges 0.35%/yr vs 0.18%/yr for SPYH.DE.
Performance
CURE.DE vs. SPYH.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE.DE achieves a -5.10% return, which is significantly lower than SPYH.DE's -1.97% return.
CURE.DE
- 1D
- 4.01%
- 1M
- 6.73%
- YTD
- -5.10%
- 6M
- -8.62%
- 1Y
- 6.04%
- 3Y*
- -2.48%
- 5Y*
- —
- 10Y*
- —
SPYH.DE
- 1D
- 3.34%
- 1M
- 0.41%
- YTD
- -1.97%
- 6M
- -0.47%
- 1Y
- 6.02%
- 3Y*
- 2.85%
- 5Y*
- 5.81%
- 10Y*
- 6.16%
CURE.DE vs. SPYH.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | -5.10% | 5.09% | 0.30% | -6.42% | -4.35% |
SPYH.DE SPDR MSCI Europe Health Care UCITS ETF | -1.97% | 7.82% | 3.98% | 7.88% | 2.61% |
Correlation
The correlation between CURE.DE and SPYH.DE is 0.50, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.50 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.41 |
Correlation (All Time) Calculated using the full available price history since Sep 8, 2022 | 0.42 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE.DE vs. SPYH.DE — Risk / Return Rank
CURE.DE
SPYH.DE
CURE.DE vs. SPYH.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) and SPDR MSCI Europe Health Care UCITS ETF (SPYH.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CURE.DE | SPYH.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.08 | ||
| Sortino ratioReturn per unit of downside risk | -0.11 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.08 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 0.30 | 0.50 | -0.20 |
| Martin ratioReturn relative to average drawdown | 0.68 | 1.10 | -0.42 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CURE.DE | SPYH.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.29 | 0.37 | -0.08 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.36 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.39 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.14 | 0.43 | -0.57 |
Drawdowns
CURE.DE vs. SPYH.DE - Drawdown Comparison
The maximum CURE.DE drawdown since its inception was -34.80%, which is greater than SPYH.DE's maximum drawdown of -26.62%. Use the drawdown chart below to compare losses from any high point for CURE.DE and SPYH.DE.
Loading charts...
Drawdown Indicators
| CURE.DE | SPYH.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.80% | -26.62% | -8.18% |
Max Drawdown (1Y)Largest decline over 1 year | -19.07% | -12.58% | -6.49% |
Max Drawdown (3Y)Largest decline over 3 years | -29.32% | -26.62% | -2.70% |
Max Drawdown (5Y)Largest decline over 5 years | — | -26.62% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -26.62% | — |
Current DrawdownCurrent decline from peak | -15.66% | -10.72% | -4.94% |
Average DrawdownAverage peak-to-trough decline | -15.12% | -8.61% | -6.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.53% | 5.73% | +2.80% |
Volatility
CURE.DE vs. SPYH.DE - Volatility Comparison
VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) and SPDR MSCI Europe Health Care UCITS ETF (SPYH.DE) have volatilities of 5.73% and 6.01%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE.DE | SPYH.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.73% | 6.01% | -0.28% |
Volatility (6M)Calculated over the trailing 6-month period | 15.20% | 12.04% | +3.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.97% | 17.05% | +2.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.74% | 15.76% | +4.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.74% | 15.82% | +4.92% |
CURE.DE vs. SPYH.DE - Expense Ratio Comparison
CURE.DE has a 0.35% expense ratio, which is higher than SPYH.DE's 0.18% expense ratio.
Dividends
CURE.DE vs. SPYH.DE - Dividend Comparison
Neither CURE.DE nor SPYH.DE has paid dividends to shareholders.
Frequently Asked Questions
CURE.DE and SPYH.DE have a correlation of 0.50, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SPYH.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SPYH.DE is cheaper with a 0.18% expense ratio, compared with 0.35% for CURE.DE.
CURE.DE tracks MVIS Global Future Healthcare ESG, while SPYH.DE tracks MSCI Europe Health Care 20/35 Capped. They also come from different issuers: VanEck and State Street. Their fees differ too: 0.35% for CURE.DE and 0.18% for SPYH.DE.
Find the right allocation for CURE.DE and SPYH.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer